The development of new cannabinoid products, expanded Medical Marijuana, Inc. operations, CBD reviews, and advocating for hemp in Europe are just some of our top headlines from this week.
Medical Marijuana, Inc. and our portfolio of companies, brands, and investments were once again in the news this week as media outlets continue to feature our company in their coverage of the booming CBD industry in the U.S. and worldwide. Keep reading for our top stories from the past few weeks.
Medical Marijuana, Inc. Investments Highlighted on Benzinga
Leading news site Benzinga featured Medical Marijuna, Inc. in their Cannabinoid R&D column by looking at innovations by a pair of companies in our portfolio of investments.
First, Benzinga looked at the new partnership between Medical Marijuana, Inc. subsidiary Kannaway and Endocanna Health, Inc. Under the new agreement, the companies will collaborate to develop and distribute endocannabinoid DNA test products.
The products, designed to provide consumers with personalized data about how cannabidiol (CBD) and other cannabinoids may interact with their body’s regulatory system, will be co-branded and sold exclusively through Kannaway®’s network of brand ambassadors.
“This partnership with Endocanna Health gives us the opportunity to provide consumers with education on how CBD can best fit into their everyday lives and helps us better target our products to meet their needs,” Medical Marijuana, Inc. CEO Stuart Titus told Benzinga. “We are excited about this partnership’s growth potential with the eventual goal of creating personalized dietary supplement products to fit one’s genetic typing and internal body chemistry.”
You can read more about this partnership here.
Benzinga also explored the recent creation of AXIM Wellness, a new division of AXIM® Biotechnologies, part of Medical Marijuana, Inc.’s portfolio of investments.
According to the article, “This new division will address the high demand for cannabinoid-based solutions worldwide through a series of patented nutraceutical products. AXIM will utilize its patent on CBD-based chewing gums to build out its nutraceutical gum line, including products targeted for migraines, athletes, smoking cessation and overall wellness. They will also focus on launching other oral care products later this year.”
“By focusing resources on our nutraceutical product line, we will be able to bring to market new products, such as our gum lines, oral care products and topicals, in high consumer impact areas. We aim to use the sales from this new wellness division to be able to self-fund many of our pharmaceutical research projects and bring additional shareholder value,” John W. Huemoeller II, CEO of AXIM, told Benzinga.
You can read the full article here.
Medical Marijuana, Inc. Expands Warehouse and Manufacturing Operation in Utah
Medical Marijuana, Inc. moved its warehousing operations to Utah to better service its distribution needs. The new facility, covering 16,000 square feet, is cGMP compliant and is registered with the State of Utah. The facility has been designed to help our companies increase warehousing, fulfillment, and production activities related to the Company’s CBD hemp oil products.
“As the Company has seen a significant rise in sales and overall revenue this year, we believe that this new facility will help us strengthen our customer base and meet the needs of today’s burgeoning cannabis market,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus of the news. “Our team is working diligently to create processes that will guarantee that this facility will create more transparent and valuable relationships with retailers and consumers around the world.”
News of our new warehouse facility was shared on the following sites:
You can read more about this story here.
Medical Marijuana, Inc. Products Reviewed
Products from across the Medical Marijuana, Inc. portfolio of products were featured in a number of media outlets covering the types of CBD oil products available and reviewing their quality.
MarijuanaBreak reviewed Medical Marijuana, Inc. and products from the Real Scientific Hemp Oil™ brand recently, giving a positive overview of the quality of our flagship RSHO™ products. The review reads, “They have a great texture, pleasant taste, and work both quickly and effectively.”
The review continues, “Overall, Medical Marijuana Inc. is a great brand with an even better range of products. The quality of this brand is evident, offering all-natural, full-spectrum CBD products for you and even your pets. And although this brand is by no means cheap, it does offer better value for money than many other CBD companies, which is a definite plus.”
You can find the full review here.
Products from our portfolio company HempMeds® product line were included in Hemp Oil Talk’s “10 Unique CBD Products You Can Buy Right Now”. The list featured HempMeds®’s Hydrating & Purifying Shampoo and Dixie Botanicals® + Surface CBD-Infused SPF50 Sunscreen.
The article reads, “Looking for ways to get more CBD into your life through unique products? We’ve rounded up 10 of the most unique, quirky, or straight-up weird ways you can bring more CBD to your daily routine.”
Read more here.
Medical Marijuana, Inc. products were also featured in the following media outlets:
Kannaway Joins European Industrial Hemp Association
Kannaway has become a member of the European Industrial Hemp Association (EIHA) and will participate in the organization’s operational and legislative activities. The EIHA is the only coalition for the industrial hemp sector in Europe. Its members, representing 31 different countries, are players in industrial hemp processing and distribution, car manufacturing, construction, food and feedstock, as well as the pharmaceutical sector.
“We’re excited to be recognized as a leader in the European hemp industry,” Kannaway Vice President of International Alex Grapov said of the news. “We look forward to working with the EIHA to help drive global policy changes regarding the legislation of hemp and CBD and help spread education on the potential wellness benefits of CBD.”